These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1801354)

  • 1. One year evaluation of immunogenicity conferred by a Chinese hamster ovary cell recombinant hepatitis B vaccine in a French Polynesian newborn immunization programme.
    Spiegel A; Boutin JP; Cartel JL; Chanteau S; Cardines R; Saliou P; Roux JF
    Trans R Soc Trop Med Hyg; 1991; 85(6):783-7. PubMed ID: 1801354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 5-year immunization field trial against hepatitis B using a Chinese hamster ovary cell recombinant vaccine in French Polynesian newborns: results at 3 years.
    Moulia-Pelat JP; Spiegel A; Martin PM; Cardines R; Boutin JP; Roux JF; Excler JL; Saliou P
    Vaccine; 1994 May; 12(6):499-502. PubMed ID: 8036822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Control of hepatitis B in French Polynesia with a program of systematic vaccination of newborns with the Genhevac B vaccine].
    Moulia-Pelat JP; Spiegel A; Excler JL; Martin P; Roux JF; Boutin JP; Blondeau C; Saliou P
    Sante; 1996; 6(1):11-5. PubMed ID: 8612008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study.
    Goh KT; Tan KL; Kong KH; Oon CJ; Chan SH
    Bull World Health Organ; 1992; 70(2):233-9. PubMed ID: 1600584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response to hepatitis B vaccine in infants and newborns: control trial in an endemic area (Senegal).
    Coursaget P; Deciron F; Tortey E; Barin F; Chiron JP; Yvonnet B; Diouf C; Denis F; Diop-Mar I; Correa P
    IARC Sci Publ; 1984; (63):319-35. PubMed ID: 6242150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Respective importance of vertical and horizontal transmission of hepatitis B in the Australian archipelago (French Polynesia). Preliminary results of the vaccination of newborns].
    Boutin JP; Spiegel A; Flye Sainte-Marie F; Cartel JL; Girard M; Saliou P; Roux J
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):906-11. PubMed ID: 1840244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibody persistence following booster vaccination with three doses of hepatitis B vaccines among low-response adults in Zhangqiu county of Shandong province: 24-month of follow-up from 2009].
    Yan B; Lyu J; Liu J; Feng Y; Xu A; Chen S; Zhou L; Liang X; Cui F; Wang F; Zhang L
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Dec; 48(12):1043-7. PubMed ID: 25619213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of a recombinant DNA hepatitis B vaccine in neonates.
    Meheus A; Alisjahbana A; Vranckx R; Sukadi A; Usman A; Ngantung W; Sugita E; Safary A; André F; Reniers J
    Postgrad Med J; 1987; 63 Suppl 2():139-41. PubMed ID: 3317350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B immunization in high risk neonates born from HBsAg positive mothers: comparison between plasma derived and recombinant DNA vaccine.
    Pongpipat D; Suvatte V; Assateerawatts A
    Asian Pac J Allergy Immunol; 1989 Jun; 7(1):37-40. PubMed ID: 2526633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yeast-derived hepatitis B vaccine in dental students. A three-year follow-up study.
    Zanetti AR; Tanzi E; Pozzi A; Romano L; Bergamini F
    Vaccine; 1990 Jun; 8(3):205-8. PubMed ID: 2194379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An efficacy trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine in infants born to mothers positive for HBsAg, in Shanghai, China.
    Halliday ML; Kang LY; Rankin JG; Coates RA; Corey PN; Hu ZH; Zhou TK; Yuan GJ; Yao FL
    Int J Epidemiol; 1992 Jun; 21(3):564-73. PubMed ID: 1386063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and protective efficacy of low dose recombinant DNA hepatitis B vaccine in normal and high-risk neonates.
    Assateerawatt A; Tanphaichitr VS; Suvatte V; In-ngarm L
    Asian Pac J Allergy Immunol; 1991 Dec; 9(2):89-93. PubMed ID: 1839654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-HBs persistence following primary vaccination with three doses of hepatitis B vaccine among normal and high-responder adults: a 3-year follow-up study].
    Lyu JJ; Zhang L; Yan BY; Liu JY; Feng Y; Song LZ; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):478-83. PubMed ID: 27256725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.
    Duval B; Gîlca V; Boulianne N; Deceuninck G; Rochette L; De Serres G
    Vaccine; 2005 Jul; 23(31):4082-7. PubMed ID: 15963363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B immunization in high risk neonates born from HBsAg and HBeAg positive mothers: comparison of standard and low dose regimens.
    Pongpipat D; Suvatte V; Assateerawatts A
    Asian Pac J Allergy Immunol; 1988 Dec; 6(2):107-10. PubMed ID: 2975491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of recombinant hepatitis B vaccine in infants born to HBsAg-positive mothers.
    Yeoh EK; Chang WK; Ip P; Chan KH; Chan E; Fung C
    J Infect; 1986 Jul; 13 Suppl A():15-8. PubMed ID: 2943811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of three different recombinant hepatitis B vaccines: GeneVac-B, Engerix B and Shanvac B in high risk infants born to HBsAg positive mothers in India.
    Velu V; Nandakumar S; Shanmugam S; Jadhav SS; Kulkarni PS; Thyagarajan SP
    World J Gastroenterol; 2007 Jun; 13(22):3084-9. PubMed ID: 17589924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunogenicity and harmlessness in the newborn of a vaccine (GenHevac B) containing the antigens S and pre-S2].
    Tron F; Soulié JC; Goudeau A; Devillier P; Saliou P
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):901-5. PubMed ID: 1840243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immediate immunological effect of China-made recombinant hepatitis B vaccine expressed by transgenic Chinese hamster ovary cell line].
    Liu H; Ma J; Meng Z; Zhang Y; Han C; Zhang Y; Zhao H; Liu Y; Xing Z; Chen J; Jia Z; Xia G; Cao H; Liu C; Li Z
    Zhonghua Yi Xue Za Zhi; 2002 Jan; 82(1):43-6. PubMed ID: 11953126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.